Merck FAKED mumps vaccine research, released faulty vaccine

New Post Public Reply Private Reply Replies (0) Message Board
Lmcat
407
Merck FAKED mumps vaccine research, released faulty vaccine that didn’t work, say virologists in False Claims Act filing

Woman-Science-Test-Vaccine-Vials-Dropper-678x381.jpg

With the deceptive “mainstream” media now running measles hysteria 24/7, you might be shocked to learn that the MMR vaccine doesn’t work as claimed.

Even Reuters is now reporting that 10% of those infected with the measles were previously vaccinated against the measles.

This stunning admission is found in an April 29 article from Reuters entitled, “U.S. measles outbreak raises questions about immunity in adults.” The article states:

Up to 10 percent of the 695 confirmed measles cases in the current outbreak occurred in people who received one or two doses of the vaccine, according to the U.S. Centers for Disease Control and Prevention.

Merck FAKED vaccine efficacy data and committed widespread scientific fraud, say virologists

If you’re wondering why so many people who were vaccinated against measles, mumps and rubella are now being infected with the measles, you have to remember that Merck faked its MMR vaccine efficacy data by spiking human blood samples with animal antibodies, according to two former Merck employees who say they were ordered by Merck management to carry out the massive science fraud.

The two Merck virologists, named Stephen Krahling and Joan Wlochowski, filed a False Claims Act document in 2010 that specifically called out Merck’s fraudulent vaccine deception as running the risk of contributing the future outbreaks of infectious disease.

That’s exactly what we’re seeing today, of course, with measles spreading across America, even among those who were previously vaccinated against measles. (Because the vaccine doesn’t work, get it?)

Natural News originally covered this story in 2012, and we preserved the original False Claims Act document at the following link, making sure it wasn’t memory-holed off the internet:

https://www.naturalnews.com/gallery/documents...ms-Act.pdf

Merck vaccine fraud exposed by two Merck virologists; company faked mumps vaccine efficacy results for over a decade, says lawsuit

According to two Merck scientists who filed a False Claims Act complaint in 2010 — a complaint which has just now been unsealed — vaccine manufacturer Merck knowingly falsified its mumps vaccine test data, spiked blood samples with animal antibodies, sold a vaccine that actually promoted mumps and measles outbreaks, and ripped off governments and consumers who bought the vaccine thinking it was “95% effective.”


See that False Claims Act document at:
https://www.naturalnews.com/gallery/documents...ms-Act.pdf

According to Stephen Krahling and Joan Wlochowski, both former Merck virologists, the Merck company engaged in all the following behavior:

• Merck knowingly falsified its mumps vaccine test results to fabricate a “95% efficacy rate.”


• In order to do this, Merck spiked the blood test with animal antibodies in order to artificially inflate the appearance of immune system antibodies. As reported in CourthouseNews.com:

Merck also added animal antibodies to blood samples to achieve more favorable test results, though it knew that the human immune system would never produce such antibodies, and that the antibodies created a laboratory testing scenario that “did not in any way correspond to, correlate with, or represent real life … virus neutralization in vaccinated people,” according to the complaint. (http://www.courthousenews.com/2012/06/27/478…)

Merck then used the falsified trial results to swindle the U.S. government out of “hundreds of millions of dollars for a vaccine that does not provide adequate immunization.”

• Merck’s vaccine fraud has actually contributed to the continuation of mumps across America, causing more children to become infected with mumps.
(Gee, really? This is what NaturalNews has been reporting for years… vaccines are actually formulated to keep the outbreaks going because it’s great for repeat business!)

• Merck used its false claims of “95 percent effectiveness” to monopolize the vaccine market and eliminate possible competitors.

• The Merck vaccine fraud has been going on since the late 1990’s, say the Merck virologists.

• Testing of Merck’s vaccine was never done against “real-world” mumps viruses in the wild. Instead, test results were simply falsified to achieve the desired outcome.

• This entire fraud took place “with the knowledge, authority and approval of Merck’s senior management.”


• Merck scientists “witnessed firsthand the improper testing and data falsification in which Merck engaged to artificially inflate the vaccine’s efficacy findings,” according to court documents (see below).

US government chose to ignore the 2010 False Claims Act!

Rather than taking action on this false claims act, the U.S. government simply ignored it, thereby protecting Merck’s market monopoly instead of properly serving justice. This demonstrates the conspiracy of fraud between the U.S. government, FDA regulators and the vaccine industry.
Chatom Primary Care sues Merck for Sherman Act monopolization, breach of warranty, violation of consumer protection laws

Following the unsealing of this 2010 False Claims Act, Chatom Primary Care, based in Alabama, smelled something rotten. Three days ago, Chatom filed a lawsuit against Merck. That lawsuit record is available here:
www.naturalnews.com/gallery/documents/Chatom…

It alleges, among other shocking things:

[Merck engaged in] …a decade-long scheme to falsify and misrepresent the true efficacy of its vaccine.

Merck fraudulently represented and continues to falsely represent in its labeling and elsewhere that its Mumps Vaccine has an efficacy rate of 95 percent of higher.

In reality, Merck knows and has taken affirmative steps to conceal — by using improper testing techniques and falsifying test data — that its Mumps Vaccine is, and has been since at least 1999, far less than 95 percent effective.

Merck designed a testing methodology that evaluated its vaccine against a less virulent strain of the mumps virus. After the results failed to yield Merck’s desired efficacy, Merck abandoned the methodology and concealed the study’s findings.

…incorporating the use of animal antibodies to artificially inflate the results…

…destroying evidence of the falsified data and then lying to an FDA investigator…

…threatened a virologist in Merck’s vaccine division with jail if he reported the fraud to the FDA…


…the ultimate victims here are the millions of children who every year are being injected with a mumps vaccine that is not providing them with an adequate level of protection.

And while this is a disease that, according to the Centers for Disease Control (‘CDC’), was supposed to be eradicated by now, the failure in Merck’s vaccine has allowed this disease to linger, with significant outbreaks continuing to occur.

Chatom Primary Care also alleges that the fraudulent Merck vaccine contributed to the 2006 mumps outbreak in the Midwest, and a 2009 outbreak elsewhere. It says, “there has remained a significant risk of a resurgence of mumps outbreaks…”

This investigation is only beginning

NaturalNews has only begun to investigate this incredible breaking news about Merck and the vaccine industry. We are pouring through the court documents to identify additional information that may be relevant to this case, and we plan to bring you that information soon.

For the record, Merck denies all allegations. Is anyone surprised?


Sources for this article:
NaturalNews wishes to thank CourthouseNews.com for its coverage of this story. Original article at: http://www.courthousenews.com/2012/06/27/478…

Chatom Lawsuit against Merck
www.naturalnews.com/gallery/documents/Chatom…

2010 False Claims Act against Merck, by two Merck virologists
www.naturalnews.com/gallery/documents/Merck-…

https://www.dcclothesline.com/2019/05/02/merc...ct-filing/
Scroll down for more posts ▼

Top 10 Most Recent News Articles

IRS Views Challenge Tax-Engineered Healthcare Schemes

Updated Category News Views 4

Nonprofit Models Shine Amid IRS Scrutiny Out in Oxnard, California, there's a brewing storm in the healthcare sector. No, it's not a billing error or yet another scandal. We're talking about a seismic shift that could poke holes in those tax-engineered Section 105(b) programs, all thanks to some hard-hitting IRS memoranda. The Nonprofit–TPA Model: A Safer Bet? Enter...

Continue Reading
GenAI Boosts Grades and Tech Savvy for Online Learners

Updated Category News Views 3

What's Really Driving GenAI Use in Online Education? Let's not beat around the bush—most folks think students turn to this newfangled generative AI mainly to smooth over academic hurdles or save time. But guess what? The University of Phoenix has gone and poked some holes in that assumption. Study Highlights Key Insights This solid piece of research from the...

Continue Reading
No Dogs Left Behind Marks Decade of Life-Saving Work

Updated Category News Views 4

A Decade of Dedication Some stories out there bring a much-needed shine to the otherwise relentless grind, and this is one of those rare gems. No Dogs Left Behind (NDLB) is celebrating a monumental milestone: ten years into their mission, they've crossed the incredible threshold of saving over 10,000 dogs from the clutches of slaughterhouses in East Asia. The nonprofit...

Continue Reading
Kobold Press Explores Roleplaying as Literacy Tool

Updated Category News Views 5

Gaming Illuminates Pathways to Literacy and Community Trust me, when an indie game publisher like Kobold Press makes waves, it's worth paying attention. They've carved a niche in the roleplaying world by marrying traditional game elements with valuable educational tools. The thrill of the game goes beyond rolling dice; it's a ticket to improving literacy, arithmetic, and...

Continue Reading
Crimson Coward's Cheez Nugs Shake Up Fast-Casual Scene

Updated Category News Views 7

New Kid on the Block: Cheez Nugs Buckle up folks, Crimson Coward is at it again. They're rolling out something they claim will blow your taste buds straight out of the water: Cheez Nugs. Dropping nationwide on September 18, 2026, these aren't your run-of-the-mill cheese bites. We're talking 100% whole-milk mozzarella, a golden herb-seasoned crust, and a mouthful of creamy...

Continue Reading
Debbie's Dream Foundation Launches 2026 Youth Art Contest

Updated Category News Views 5

Young Artists Called to Inspire a Cancer-Free World What's the first image that pops into your head when you think of a world free from cancer? That's the magic question on deck for this year's Youth Art Contest by Debbie's Dream Foundation. Imaginations are set to run wild as the competition opens its gates to artists under 18, calling for visions splashed across...

Continue Reading
DAHON's Tech: Crafting Folders That Ride Like Road Bikes

Updated Category News Views 4

The Folding Bike Revolution: More Than Just a Fad You've seen them zipping around—those compact, folding bikes. They're not just for urban commuters looking to save space. Oh no, this is a full-blown cycling revolution we're talking about. DAHON, a name that's been rolling since 1982, has been riding these waves and making strides that others can only dream of. While...

Continue Reading
Chattanooga: A New Epicenter for Quantum Computing

Updated Category News Views 4

Quantum Leap: Chattanooga's Bold Move So Chattanooga’s making waves again, folks. EPB just unveiled its new big shot, the IonQ Forte Enterprise quantum computer. That's right, they’ve slapped a commercial quantum computer and a networking hub together, right here in this Tennessee city. Is this a tech haven or what? Not to mention, it’s the first in America. A New...

Continue Reading
Ensuring Your Radon Mitigation System Stays Effective

Updated Category News Views 2

Radon Mitigation: A Critical Measure for Home Safety Homeowners, you're probably aware of the ticking health time bomb known as radon. Not just an annoying gas, this colorless, odorless beast lurks quietly, threatening family health if not managed right. Mitch Kelley, a specialist in radon testing with Basement Solutions in Mankato, Minnesota, lays out a no-fuss guide to...

Continue Reading
FOSSI Opens 2027 Applications for Future STEM Leaders

Updated Category News Views 3

Paving Pathways in the Chemical Industry There's something brewing that's got me eyeing the future with cautious optimism, and it doesn't involve hedge funds or earnings reports. It's the Future of STEM Scholars Initiative (FOSSI) playing its cards just right, planting seeds for tomorrow's innovators. This puppy opened the gates for 2027 applications, and for young brains...

Continue Reading

Top 5 Most Recently Viewed Articles

Kvika Bank hf. Welcomes New Board Member Sigurgeir Guðlaugsson

Updated Category News Views 84

Kvika Bank hf. Welcomes New Board Member Kvika banki hf. has recently made a notable addition to its board of directors by appointing Sigurgeir Guðlaugsson as a new member. Sigurgeir has been serving as a deputy on the board since 2021 and brings a wealth of experience to the role, currently acting as the CEO of Genís hf. Insight into Sigurgeir Guðlaugsson's Background...

Continue Reading
Sealed Air Announces Quarterly Dividend Boost for Shareholders

Updated Category News Views 167

Sealed Air Dividend Announcement Sealed Air (NYSE: SEE) has made an exciting announcement regarding its commitment to returning value to its shareholders. The company has declared a quarterly cash dividend of $0.20 per common share. This dividend showcases Sealed Air's dedication to maintaining strong financial performance and providing consistent returns to its...

Continue Reading
EPAM Expands Services with Acquisition of First Derivative

Updated Category News Views 95

EPAM Systems Announces Strategic Acquisition EPAM Systems, Inc. (NYSE: EPAM) has taken a significant step forward in enhancing its financial services division through a strategic agreement to acquire First Derivative, a well-respected consulting and managed services firm for the capital markets sector. This acquisition is set to broaden the capabilities EPAM offers in...

Continue Reading
Market Review: US Stocks Face Slight Decline Amid Earnings

Updated Category News Views 74

Market Overview: US Stocks Experience Decline US stocks faced a minor retreat, with many indexes moving lower as traders reassess their positions following last week's record-breaking performances. Despite the drop, there is an air of cautious optimism circulating among investors as the earnings season kicks into high gear. Investors Shift Focus to Earnings Reports As...

Continue Reading
Titan International Strengthens Leadership for Growth and Innovation

Updated Category News Views 232

Titan International Strengthens Leadership for Growth and Innovation Titan International, Inc. (NYSE: TWI), a prominent global manufacturer specializing in off-highway wheels, tires, assemblies, and undercarriage products, has announced a series of executive transitions intended to enhance its leadership structure and bolster the company's strategic initiatives. This...

Continue Reading